about
To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory TherapiesFate of lymphocytes after withdrawal of tofacitinib treatmentPiccolipiù, a multicenter birth cohort in Italy: protocol of the study.Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research.Alendronate, a double-edged sword acting in the mevalonate pathway.Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds.Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes.Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media.In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords.The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation.Selective resistance to different glucocorticoids in severe autoimmune disorders.Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations.PReS-FINAL-2338: Fate of lymphocytes after withdrawal of Tofacitinib treatment.From bone marrow transplantation to cellular therapies: possible therapeutic strategies in managing autoimmune disorders.Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis.T cells stimulated in vitro have a suppressive function but do not contain only regulatory T cells.Neuronal Dysfunction Associated with Cholesterol Deregulation.Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype.Immunomodulatory drugs in autoimmune lymphoproliferative syndrome (ALPS)Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytesRegulatory T-Cell Function Is Impaired in Celiac DiseaseHemophagocytic Lymphohistiocytosis in Total Parenteral Nutrition Dependent ChildrenMedium-term survival without haematopoietic stem cell transplantation in a case of IPEX: insights into nutritional and immunosuppressive therapyImpact of methylmercury and other heavy metals exposure on neurocognitive function in children of 7 years old: study protocol of the follow-upOff-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature
P50
Q26786973-B6EFD0F2-8F6F-462D-9FF8-FADD201DC042Q28538586-F339A616-2469-4F93-AEBE-4AA7D44A13F9Q35088928-52A61350-D7C8-4BA6-AAFB-2E49292955ECQ35375821-F0686DD6-6B3C-473F-82C2-7DBBE9D852A9Q38369585-6C4E2EE6-9F57-43F6-9FCA-4574C7398552Q38861481-4A124FE5-3B1B-4DFD-8D02-EBD97B52C0E4Q39001725-366C0A8D-CFEC-4167-9E18-2A3557065F6DQ39769170-0361537E-9A7B-4B4C-B34A-E728B66C1534Q40629517-EAADF2D6-FBCA-41C0-8DAE-81483198951AQ42231868-83B7D41D-D928-41C1-B08F-9891EFC2D9FEQ43193050-47382D69-BD7E-4905-B818-B9865879C8CAQ43229421-1EE97A6F-88F6-44C2-B8D3-01B212E298E4Q45888264-3B040AD1-34A1-415A-AB1C-DBBD88CFA00FQ47141705-553425CF-E055-4423-B902-62EBB9AFD5CFQ47587198-0B17A042-2AC8-4281-BA44-36C68010869BQ50505903-615E59A5-57BF-4562-8B9A-1A20D0BFD331Q51976612-0D6FFC6C-6744-4390-88FC-96B0697ACF57Q54108334-19491264-8A6F-4020-9658-20694827ECFDQ54274139-591DBF57-997F-4D05-8F74-74D378EEE068Q62022597-345F7BAF-3158-4B8E-BAAC-03790616E9A3Q62022599-7452316D-AB3C-47C0-9456-7078FD8F828FQ62022602-CA625EC7-04D7-44FD-AD02-CEF1C86A433DQ62513304-C602A34B-CBBC-416C-B280-1BAC48354D7DQ63343212-0161993C-B29C-4954-B6F0-B3F2B34FF1C4Q91579473-6E615E79-7DA7-4143-8103-ADE1C0865138Q92261117-AFC5F59A-286F-419D-9CF4-45227DABCD9D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Erica Valencic
@ast
Erica Valencic
@en
Erica Valencic
@es
Erica Valencic
@nl
Erica Valencic
@sl
type
label
Erica Valencic
@ast
Erica Valencic
@en
Erica Valencic
@es
Erica Valencic
@nl
Erica Valencic
@sl
prefLabel
Erica Valencic
@ast
Erica Valencic
@en
Erica Valencic
@es
Erica Valencic
@nl
Erica Valencic
@sl
P1053
G-3067-2014
P106
P1153
12039662900
P21
P31
P3829
P496
0000-0002-7380-8014